Breast Carcinoma Panel
A diagnostic panel that tests for genetic markers and protein expressions associated with breast cancer. It helps in determining cancer subtypes and guiding treatment decisions. The panel includes markers such as HER2, estrogen receptors, and progesterone receptors.
Breast Carcinoma Panel Test Overview
What is Breast Carcinoma Panel test?
Breast Carcinoma Panel test includes a group IHC markers that help assess the presence, type, and progression of breast cancer. It includes tests for hormone receptors (ER, PR), HER2/neu, Ki-67. This panel is particularly useful for diagnosing breast cancer, determining its aggressiveness, and planning personalized treatment strategies.
Why consider Breast Carcinoma Panel test?
Breast Carcinoma panel test can be considered for below clinical conditions
- To help diagnose breast cancer and differentiate it from benign breast conditions.
- To monitor the progression or recurrence of breast cancer during and after treatment.
- To assess prognostic factors and help guide therapy (e.g., hormone therapy, HER2-targeted therapy).
- To evaluate response to treatment or detect metastasis.
- Sometimes used for screening in high-risk patients, though not as a primary screening tool.
Who should get tested for Breast Carcinoma Panel test?
Patients diagnosed with or suspected of having breast cancer, especially those with a family history of breast or ovarian cancer, are candidates for this panel. It may also be suggested for those undergoing biopsy or surgery for breast lesions to guide prognosis and therapy.
More Information
OTHER NAMES: Breast Tumor Marker Panel, Breast Cancer Biomarker Panel, Breast Cancer Diagnostic Panel, Breast Cancer Marker Panel
Breast cancer is the uncontrolled growth of breast cells. It can start in the milk ducts or lobules and may spread to other parts of the body if not detected early. Breast cancer diagnostics aim to detect cancer early, confirm a diagnosis, determine cancer type, stage, and receptor status and guide treatment decisions.
No special preparations needed
- Request Letter
- Additional Communication
- Specimen
- Microscopy
- Estrogen Receptor
- % Er Positive
- Progesterone Receptor
- % Pgr Positive
- Request Letter
- Additional Communication
- Specimen
- Microscopy
- Her2/neu Oncoprotein
- Request Letter
- Additional Communication
- Ki-67
Test code
1692
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Paraffin Block | Others | 101 MG |
| Tissue | Others | 10 |
Specimen stability information
Paraffin Block, Tissue
Collection instructions
Tissue In 10% Neutral Buffered Formalin For 24-48 Hrs/ Paraffin Block+ Site Of Biopsy , Clinical Details & Primary Histopathology Report Mandatory. If Tissue Received It Will Be Charged For Tissue Processing.* Time And Duration Of Fixation Should Be Mentioned On The TRF.*
Specimen rejection criteria
Test run frequency
'
Turn around time
3 Working Days
Performing locations
Department
- Histopath
CPT and Loinc codes
Package price
₹5000
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestBreast Carcinoma Panel
₹5000